HB
Harold Bernstein
President, R&D & CMO

Harold Bernstein insider trades: Maze Therapeutics (MAZE) stock sales

President, R&D & CMO, Maze Therapeutics Last trade Oct 1, 2026 14 Form 4 filings
$8.1M
Sold, last 12 months
13 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2025
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Harold reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 1, 2026MAZE↓ Sell$435K
Sep 4, 2026MAZE↓ Sell$255K
Sep 3, 2026MAZE↓ Sell$270K
Sep 1, 2026MAZE↓ Sell$426K
Aug 13, 2026MAZE↓ Sell$446K
Jul 1, 2026MAZE↓ Sell$437K
Jun 1, 2026MAZE↓ Sell$381K
Apr 1, 2026MAZE↓ Sell$442K
Mar 20, 2026MAZE↓ Sell$736K
Mar 10, 2026MAZE↓ Sell$1.5M
Feb 2, 2026MAZE↓ Sell$690K
Jan 5, 2026MAZE↓ Sell$196K
Dec 29, 2025MAZE↓ Sell$1.8M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other MAZE insiders

Open-market trades in the last 12 months

About Harold Bernstein's insider trades

Harold Bernstein is President, R&D & CMO at Maze Therapeutics (MAZE). Since Dec 29, 2025, Harold has reported no open-market purchases and 13 sales worth $8.1M on SEC Form 4. In the last 12 months: 13 sales ($8.1M).

Their filings also include option exercises (11 filings), grants and awards (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MAZE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.